The role of MRI in the assessment of polymyositis and dermatomyositis

Rheumatology

Volumn 46, Issue 7, 2007, Pages 1174-1179

  Tomasova Studynkova J ^a   Charvat F ^b   Jarosova K ^a   Vencovsky J ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Czech Republic)

^b Radiodiagnostic Department   (Czech Republic)

Author keywords

Dermatomyositis; Histopathology; Magnetic resonance imaging; Polymyositis

Indexed keywords

AZATHIOPRINE; CYCLOSPORIN A; METHOTREXATE; PREDNISONE;

ACUTE DISEASE; ADULT; AGED; ARTICLE; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; CORRELATION ANALYSIS; DERMATOMYOSITIS; DIAGNOSTIC VALUE; DISEASE ACTIVITY; DISEASE SEVERITY; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; INFLAMMATORY CELL; MALE; MUSCLE BIOPSY; NEEDLE BIOPSY; NUCLEAR MAGNETIC RESONANCE IMAGING; POLYMYOSITIS; PRIORITY JOURNAL; SCORING SYSTEM; VISUAL ANALOG SCALE;

ADULT; AGED; BIOPSY, NEEDLE; DERMATOMYOSITIS; EDEMA; FEMALE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; MUSCLE, SKELETAL; POLYMYOSITIS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 34447309330     PISSN: 14620324     EISSN: 14620332     Source Type: Journal    
DOI: 10.1093/rheumatology/kem088     Document Type: Article

References (30)

1. Dalakas M. Polymyositis, dermatomyositis, and inclusion body myositis. N Engl J Med 1991;325:1487-98.
2. Bohan A, Peter JB. Polymyositis and dermatomyositis (First of two parts). N Engl J Med 1975;292:344-7.
3. Bohan A, Peter JB. Polymyositis and dermatomyositis (Second of two parts). N Engl J Med 1975;292;403-7.
4. Messner RP. Pathogenesis of idiopathic inflammatory myopathies. In: Wortmann RL, ed. Diseases of sceletal muscle. Philadelphia: Lippincott Williams & Wilkins, 2000:111-28.
5. Studynkova JT, Kuchen S, Jelsy E et al. The expression of cyclooxygenase-1, cyclooxygenase-2 and 5-lipoxygenase in inflammatory muscle tissue of patients with polymyositis and dermatomyositis. Clin Exp Rheumatol 2004;22:395-402.
6. Lampa J, Nennesmo I, Einarsdottir H, Lundberg I. MRI guided muscle biopsy confirmed polymyositis diagnosis in a patient with interstitial lung disease. Ann Rheum Dis 2001;60:423-6.
7. Pitt AM, Fleckenstein JL, Greenlee RG Jr, Burns DK, Bryan WW, Haller R. MRI-guided biopsy in inflammatory myopathy: Initial results. Magn Reson Imaging 1993;11:1093-9.
8. Vencovský J, Jarošová K, Charvát F. The use of magnetic resonance imaging in diagnostics and evaluation of the activity in patients with idiopathic inflammatory myopathies (in Czech). Ces Revmatol 1997;5:163-8.
9. Fujino H, Kobayashi T, Goto I, Onitsuka H. Magnetic resonance imaging of the muscles in patients with polymyositis and dermatomyositis. Muscle Nerve 1991;14:716-20.
10. Yosipovitch G, Beniaminov O, Rousso I, David M. STIR magnetic resonance imaging: A noninvasive method for detection and follow-up of dermatomyositis. Arch Dermatol 1999;135:721-3.
11. Adams EM, Chow CK, Premkumar A, Plotz PH. The idiopathic inflammatory myopathies: Spectrum of MR imaging findings. Radiographics 1995;15:563-74.
12. Fraser DD, Frank JA, Dalakas M, Miller FW, Hicks JE, Plotz P. Magnetic resonance imaging in the idiopathic inflammatory myopathies. J Rheumatol 1991;18:1693-700.
13. Reimers CD, Schedel H, Fleckenstein JL. et al. Magnetic resonance imaging of skeletal muscles in idiopathic inflammatory myopathies of adults. J Neurol 1994;241:306-14.
14. Kaufman LD, Gruber BL, Gerstman DP, Kaell AT. Preliminary observations on the role of magnetic resonance imaging for polymyositis and dermatomyositis. Ann Rheum Dis 1987;46:569-72.
15. Rider LG, Feldman BM, Perez MD et al. Development of validated disease activity and damage indices for the juvenile idiopathic inflammatory myopathies: I. Physician, parent, and patient global assessments. Juvenile Dermatomyositis Disease Activity Collaborative Study Group. Arthritis Rheum 1997;40:1976-83.
16. Vencovský J, Jirásek A, Valenta J, Tmavský K. Clinico-morphological correlation in polymyositis and dermatomyositis. Scand J Rheumatol 1988;67S:32-35.
17. Hernandez RJ, Sullivan DB, Chenevert TL, Keim DR. MR imaging in children with dermatomyositis: Musculoskeletal findings and correlation with clinical and laboratory findings. Am J Roentgenol 1993;161:359-66.
18. Hernandez RJ, Keim DR, Chenevert TL, Sullivan DB, Aisen AM. Fat-suppressed MR imaging of myositis. Radiology 1992;182:217-9.
19. Keim DR, Hernandez RJ, Sullivan DB. Serial magnetic resonance imaging in juvenile dermatomyositis. Arthritis Rheum 1991;34:1580-4.
20. Hernandez RJ, Keim DR, Sullivan DB, Chenevert TL, Martel W. Magnetic resonance imaging appearance of the muscles in childhood dermatomyositis. J Pediatr 1990;117:546-50.
21. Stonecipher MR, Jorizzo, JL, Monu J, Walker F, Sutej PG. Dermatomyositis with normal muscle enzyme concentrations. A single-blind study of the diagnostic value of magnetic resonance imaging and ultrasound. Arch Dermatol 1994;130:1294-9.
22. Kiely PD, Heron CW, Bruckner FE. Presentation and management of idiopathic inflammatory muscle disease: Four case reports and commentary from a series of 78 patients. Rheumatology 2003;42:575-82.
23. Isenberg DA, Allen E, Farewell V et al. International Myositis and Clinical Studies Group (IMACS). International consensus outcome measures for patients with idiopathic inflammatory myopathies. Development and inital validation of myositis activity and damage indices in patients with adult onset disease. Rheumatology 2004;43:49-54.
24. Hilario MO, Yamashita H, Lutti D, Len C, Terreri MT, Lederman H. Juvenile idiopathic inflammatory myopathies: The value of magnetic resonance imaging in the detection of muscle involvement. Sao Paulo Med J 2000;118:35-40.
25. Chapman S, Southwood TR, Fowler J, Ryder CA. Rapid changes in magnetic resonance imaging of muscle during the treatment of juvenile dermatomyositis. Br J Rheum 1994;33:184-6.
26. Park JH, Vital TL, Ryder NM et al. Magnetic resonance imaging and P-31 magnetic resonance spectroscopy provide unique quantitative data useful in the longitudinal management of patients with dermatomyositis. Arthritis Rheum 1994;37:736-46.
27. Lundberg I, Kratz AK, Alexanderson H, Patarroyo M. Decreased expression of interleukin-1alpha, interleukin-1beta, and cell adhesion molecules in muscle tissue following corticosteroid treatment in patients with polymyositis and dermatomyositis. Arthritis Rheum 2000;43:336-48.
28. Dorph C, Englund P, Nennesmo I, Lundberg IE. Signs of inflammation in both symptomatic and asymptomatic muscles from patients with polymyositis and dermatomyositis. Ann Rheum Dis 2006;65:1565-71.
29. Lundberg IE, Dastmalchi M. Possible pathogenic mechanisms in inflammatory myopathies. Rheum Dis Clin North Am 2002;28:799-822.
30. Hengstman GJD, van Venrooij WJ, Vencovsky J, Moutsopoulos HM, van Engelen BG. The relative prevalence of DM and PM in Europe exhibits latitudinal gradient. Ann Rheum Dis 2000;59:141-2.